General Dermatology

The organizations called for skin health to be considered a global public health priority in a recent side meeting at the World Health Assembly.

Two new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.

VYNE Therapeutics Inc. shared that top-line data from the trial is expected in the second half of 2024.

A recent review found that teledermatology could improve patient access, increase efficiency, and cut down on costly hospital admissions.

A recent study investigated the technology as a resource for patients seeking online medical information.

Step therapy can delay appropriate care and potentially worsen patients' conditions, writes Dermatology Times Spring Editor in Chief Aaron Farberg, MD.

Renata Block, MMS, PA-C, discusses contracts, work environments, and more with SDPA presenter and past president Gina Mangin, MPAS, PA-C.

The SDPA President Elect shared insights, hopes for the field, and the importance of leadership.

The June issue of Dermatology Times features a collection of articles related to e-cigarette use and skin, Acne Awareness Month, and more.

This special literature review yields a deeper understanding of issues like treating acne, nutraceuticals, and more.

Laura Bush, DMSc, PA-C, DFAAPA, talks to Renata Block, MMS, PA-C, about her SDPA presidency, the future, and the importance of a positive outlook.

Poster presented at the SDPA conference reported Effisayil 2 data indicating spesolimab improved Dermatology Life Quality Index scores in patients with generalized pustular psoriasis.

Renata Block, MMS, PA-C, and Faseeha Raza, PA-C, discuss the DPAF, philanthropy, leadership, and the importance of patient care.

The JAK inhibitors have demonstrated efficacy, yet some clinicians are still wary of prescribing them. Amy Spizuoco, DO, FAOCD, shares tips to help clinicians improve their comfort in using them.

What are some of the opportunities and challenges facing PAs today? Renata Block, MMS, PA-C, shares insights and reflections on the field.

Researchers found dupilumab improved itch and skin lesions regardless of atopic disease status in patients with PN.

Session at the 2024 SDPA Annual Summer Dermatology Conference helps clinicians reframe beauty and empower patients.

Turn Therapeutics' Bradley Burnam recently spoke with Dermatology Times.

Click here to answer today's poll and read more about providing patients with multidisciplinary care.

Jason Hawkes, MD, MS, breaks down boxed warning pros and cons and research addressing several boxed warnings.

Keep up with the latest headlines in dermatology from the past week, including US sunscreen versus global regulations, all-time high melanoma rates in the UK, and more.

Marc Serota, MD, provided clinical pearls to consider for patients on biologics, particularly dupilumab.

Improvements persisted through the 12-week post-treatment follow-up, indicating sustained efficacy even after discontinuation of dupilumab.

Dermatology Times is looking back on the top stories in dermatology from the month of May.

Novartis announced late-breaking data for the BTK inhibitor at the 2024 European Academy of Allergy and Clinical Immunology Congress.